A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

Inclusion Criteria: \<Hepatic impairment patient\> * age: 20 - 64 years * sex: male * Child-Pugh score A or Child-Pugh score B * body weight: greater than 55 kg * written informed consent \<Healthy volunteer\> * age: 20 - 64 years * sex: male * body weight: greater than 55 kg * written informed consent Exclusion Criteria: \<Hepatic impairment patient\> * portosystemic shunt surgery * Child-Pugh score C * creatinine clearance \< 80mL/min * ascites \<Healthy volunteer\> * AST(SGOT), ALT(SGPT) \> 1.5 times of Upper Normal Range * Total bilirubin \> 1.5 times of Upper Normal Range * positive drug or alcohol screening